This is the case of a surgery performed on a 73-year-old man with severe aortic stenosis and severe coronary artery disease of both left anterior descending (LAD) and right coronary (RCA) arteries. Surgery included the implantation of a no. 21 St. Jude Trifecta aortic bioprosthesis (Saint Jude Inc, United States) and surgical coronary artery revascularization of left internal mammary artery to the LAD (LIMA-LAD) and saphenous vein to right coronary artery (SV-RCA). The patient presented with signs of progressive exertional angina pectoris exactly 1 month after surgery in an external consultation.
The transthoracic echocardiogram revealed the presence of a normally functioning aortic valvular bioprosthesis. The coronary angiography confirmed the already known native coronary artery disease, a patent LIMA-LAD grafting, and a SV grafting that remained unconnected to the distal RCA filling the coronary venous sinus (figure 1 and video 1 of the supplementary data). The cardiac computed tomography (CT) scan confirmed the connection between the SV grafting and the middle cardiac vein that eventually drains into the coronary sinus (figure 2). The RCA was percutaneously revascularized by implanting 1 drug-eluting stent. In a medical-surgical session it was decided to close the SV grafting with the implantation of a 6 mm x 12 mm AVP4 (Abbot, United States) that turned out successful (figure 3 and video 2 of the supplementary data). The patient’s angina pectoris became alleviated after percutaneous revascularization and right chamber dilatation was prevented with the closure of the SV grafting.

Figure 1.

Figure 2.

Figure 3.
We should know the surgical coronary complications and bring alternative solutions to the table. This promotes collaboration between clinical cardiology, interventional cardiology, and cardiovascular surgery
All procedures were performed according to the ethical standards established by the institutional and national research ethics committee and in full compliance with the Declaration of Helsinki from 1964 and further amendments or comparable ethical standards. The study patient’s informed consent was obtained.
FUNDING
None whatsoever.
AUTHORS’ CONTRIBUTIONS
R. Mori: data and figure curation, drafting of the original manuscript. D. Gemma: data and figure curation, drafting of the original manuscript. A. Casado: drafting of the original manuscript. F. Sliwinsky: drafting of the original manuscript. A. Romero: data and figure curation, drafting of the original manuscript. J. Palazuelos: idea, supervision, review, and edition.
CONFLICTS OF INTEREST
None whatsoever.
SUPPLEMENTARY DATA
Vídeo 1. Mori R. DOI: 10.24875/RECICE.M22000352
Vídeo 2. Mori R. DOI: 10.24875/RECICE.M22000352
This is the case of a 68-year-old woman admitted due to polytrauma following a fall from a great height. While on mechanical ventilation she shows signs of self-limited hemoptysis without hemodynamic impairment. Several computed tomography (CT) scans reveal the presence of a 20 mm × 15 mm × 15 mm pseudoaneurysm at right upper lobe branch level without any data of active bleeding or erosion, but presence of progressive growth (5 mm) in 3 successive CT scans performed within 5 days (figure 1, arrows). Given the risk of rupture, percutaneous coronary intervention is attempted to seal the pseudoaneurysm. All the corresponding informed consents were obtained.

Figure 1.
The angiography confirms the presence of the pseudoaneurysm including the bifurcation of 2 lobar branches (figure 2A, arrow; video 1 of the supplementary data) unsuitable for sealing with coils or intravascular plug and without a clear proper landing zone for stenting, which is why it is decided to implant a covered stent towards the upper subdivision to isolate it. Using a Judkins right 4 catheter (Launcher, Medtronic, United States) selective catheterization is achieved by advancing a 0.035 in guidewire. Afterwards, a 7-Fr Destination sheath (Terumo, Japan) is advanced through which a 6 mm × 28 mm Begraft expanded polytetrafluoroethylene (ePTFE)-covered stent (Bentley InnoMed, Germany) is implanted. The stent proximal region is postdilated with a 10 mm × 30 mm semicompliant Crystal Balloon (Balt, France). The pseudoaneurysm total exclusion is confirmed on the angiographic follow-up (figure 2B-F, arrow; video 2 of the supplementary data). The patient’s clinical progression is good, and she currently remains asymptomatic without clinical or radiographic data of pulmonary infarction at 6-month follow-up.

Figure 2.
FUNDING
None reported.
AUTHORS’ CONTRIBUTIONS
All the authors contributed equally to the drafting of this manuscript.
CONFLICTS OF INTEREST
None whatsoever.
SUPPLEMENTARY DATA
Vídeo 1. Fernández González L. DOI: 10.24875/RECICE.M22000350
Vídeo 2. Fernández González L. DOI: 10.24875/RECICE.M22000350
* Corresponding author.
E-mail address: luisfg82@hotmail.com (L. Fernández González).
Transcatheter aortic valve implantation (TAVI) success rate is very high and has a low rate of complications. Therefore, the number of TAVIs has been increasing worldwide. However, complications such as paravalvular leak (PVL) or permanent pacemaker implantation (PPMI) need still to be resolved, particularly in younger patients.
At this point, new technologies may help solve these problems. The FEops HEARTguide is a software that simulates the interaction between the device and patient’s anatomy (figure 1A,B). FEops provides the operator with different options and device sizes in a higher or deeper position (EVOLUT no. 26 and no. 29, Medtronic, United States), predicts the theoretical membranous septum, and the device contact pressure by analyzing the tissue characteristics of patient´s anatomy in the computed tomography (CT) images or risk of residual PVL or PPMI (figure 1C-H). Therefore, preoperative planning with FEops can be used to choose the most suitable size and device position for each patient.

Figure 1.
On the other hand, synchronized co-registration CT-fluoro has proven useful during TAVI. This is the first case ever performed worldwide using FEops image co-registration with live fluoroscopy in a TAVI procedure (figure 2, video 1 of the supplementary data; red circle: marks the membranous septum). However, no live correlation with heart and lung movements is its main limitation.

Figure 2.
In conclusion, FEops is potentially useful in TAVI not only for preoperative planning but also co-registration with fluoroscopy imaging during the procedure may reduce the complications associated with TAVI, especially in complex anatomies. Also, it can reduce the contrast used and the learning curve regarding difficult anatomies.
Written and oral informed consent were obtained before performing the procedure and for publication purposes.
FUNDING
None whatsoever.
AUTHORS’ CONTRIBUTIONS
All the authors participated in this manuscript, reviewed, and fully agreed on its content.
CONFLICTS OF INTEREST
I. Cruz Gonzalez is a proctor and consultor for Medtronic.
SUPPLEMENTARY DATA
Vídeo 1. Antúnez-Muiños PJ. DOI: 10.24875/RECICE.M22000349
This is the case of a 78-year-old man with revascularized coronary artery disease 10 years ago (left anterior descending coronary artery and left circumflex artery) who was admitted to the hospital with signs of ST-segment elevation acute coronary syndrome. The angiography shows an unusual image on the proximal left anterior descending coronary artery that seems to be causing an angiographically significant stenosis (figure 1A,B). To confirm diagnosis, a catheter is unsuccessfully advanced with optical coherence tomography (OCT) guidance through a polymeric guidewire while trying to cross the most stenotic region. Two attempts are made after predilatation (with balloons of 1.5 mm and 2.5 mm in diameter) that prove unsuccessful. Afterwards, a guide catheter extension system is advanced (figure 1D) that successfully crosses the lesion facilitating the OCT that reveals the presence of an underexpanded coronary stent with complete endothelization, and a possible thrombus attached to it (figure 1C). Upon suspicion that this is the culprit lesion, decision is made to treat it. To crush the underexpanded stent against the lumen of the vessel, it is first effortlessly predilated using a 3.5 mm x 12 mm balloon. Afterwards, a 3.5 mm x 15 mm drug-eluting stent is implanted with good angiographic results (figure 1E). A new OCT confirms the excellent expansion of the new stent including the entire forgotten stent that is crushed between the new stent and the vessel endothelium (figure 1F).

Figure 1.
Stent loss inside the coronary tree is a rare complication that can, however, be solved if removed during the procedure. However, when forgotten for years, the stent endothelizes and its extraction becomes complicated and is no stranger to complications. In these cases, the most efficient option is to exclude it by implanting a new drug-eluting stent.
The patient’s written informed consent was requested before publishing this article.
FUNDING
None whatsoever.
AUTHORS’ CONTRIBUTIONS
All the authors were involved in the procedure. They also reviewed the images and drafted the manuscript.
CONFLICTS OF INTEREST
R. Moreno in an associate editor of REC: Interventional Cardiology; the journal’s editorial procedure to ensure impartial handling of the manuscript has been followed.
This is the case of a 75-year-old man who underwent coronary angiography due to new-onset dyspnea and left bundle branch block with a long, diffuse, and heavily calcified lesion with a maximum stenosis of 90% in his dominant right coronary artery. Patient was treated with complex percutaneous coronary intervention (PCI) (double-guidewire technique—both hydrophilic wires—guide catheter extension system, and compliant and non- compliant balloon dilatations), which eventually led to the successful distal-to-proximal implantation of 3 drug-eluting stents. A few hours later, he complained of pleuritic chest pain while remaining hemodynamically stable, and with a normal physical examination. Lab tests showed troponin I levels of 8 ng/mL (reference < 0.012 ng/mL). The echocardiogram showed no regional motion abnormalities, but revealed the presence of a 55.3 mm x 29 mm left atrial mass emerging from the posterior atrial wall almost occluding the complete atrial cavity without conditioning significant mitral valve dysfunction or an impaired transmitral flow. Pericardial effusion suggestive of hemopericardium was also described (figure 1A; video 1 of the supplementary data). Left atrial intramural hematoma (LAIH) was suspected and CCTA confirmed the lesion high attenuation (56 Hounsfield Units), which was suggestive of hematic component (*, figure 1B-F). The patient remained hospitalized until the stability of the lesion was confirmed (discharge size, 48 mm x 28 mm) while on dual antiplatelet therapy. After monthly clinical follow-ups, the control CCTA performed at 3 months confirmed significant reduction (30 mm x 20 mm) (*, figure 1G-I). LAIH is a rare complication associated with complex PCI procedures (probably caused while positioning the guidewires, penetrating distal vasculature, and causing the bleeding) being a potential cause for conduction disorders and hemodynamic instability. The patient’s verbal consent was obtained.

Figura 1.
FUNDING
None whatsoever.
AUTHORS’ CONTRIBUTIONS
L. Nieto-Roca, M. Tomás-Mallebrera, and R. Carda Barrio: contributed substantially to the drafting of this case, obtained the patient’s informed consent, and compiled all the images. They gave their approval to the manuscript final version. They take full responsibility for all aspects related to the article and commit themselves to investigating and solving all questions regarding the accuracy and truthfulness of any part of the work. J.A. Esteban-Chapel, and M.L. Martín-Mariscal contributed to the interpretation of the case, and the corresponding images. They gave their approval to the manuscript final version. They take full responsibility for all aspects related to the article and commit themselves to investigating and solving all questions regarding the accuracy and truthfulness of any part of the work.
CONFLICTS OF INTEREST
None reported.
SUPPLEMENTARY DATA
Vídeo 1. Nieto-Roca L. DOI: 10.24875/RECICE.M22000329
Original articles
Editorials
Current state of knowledge on the use of drug-coated balloon in coronary bifurcation lesions
Departamento de Cardiología, Hospital Universitario de Badajoz, Badajoz, Spain
Original articles
High rate of uncovered struts in latest generation drug-eluting stents with durable, biodegradable polymer or lack of it 1 month after implantation
aServicio de Cardiología, Hospital del Mar, Barcelona, Spain
bDepartament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
cServicio de Cardiología, Hospital Universitario Bellvitge, Barcelona, Spain
dCentro de Investigaciones Biomédicas en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
eInstitut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain
fFacultat de Medicina, Universitat de Vic – Universitat Central de Catalunya, Vic, Barcelona, Spain
gServicio de Cardiología, Hospital Son Espases, Palma de Mallorca, Mallorca, Spain
hServicio de Cardiología, Hospital Universitari I Politècnic La Fe, Valencia, Spain
iServicio de Cardiología, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Santiaria Valdecilla (IDIVAL), Santander, Cantabria, Spain
Editorials
Ischemic postconditioning and duration of previous ischemia
aUnidad de Críticos Cardiovasculares, Servicio de Cardiología, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
bUniversitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain
cCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
Scientific letters
Debate
Debate: Drug-coated balloons for de novo coronary artery lesions
Still not enough evidence, and the new drug-eluting stents are still better
Sección de Hemodinámica y Cardiología Intervencionista, Servicio de Cardiología, Instituto Cardiovascular, Hospital Clínic, IDIBAPS, Barcelona, Spain
Evidence available and potential superiority in some settings
Cardiovascular Research Group, Fondazione Ricerca e Innovazione Cardiovascolare, Milan, Italy

Percutaneous treatment of partial anomalous pulmonary venous connection with dual drainage
How would I approach it?
Felipe Hernández Hernández
Case resolution
Rafael González-Manzanares, Soledad Ojeda, et al.